Analyst
TD Cowan
Equibles does not estimate personal net worth.
Dan Brennan is recorded as Analyst at TD Cowan. Dan Brennan has spoken on 9 earnings calls and 1 other investor event across 7 companies, most recently for Quanterix Corp on August 10, 2026. Those appearances were for GeneDx Holdings Corp. (WGS), Quanterix Corp (QTRX), Natera, Inc. (NTRA), Avantor, Inc. (AVTR), Thermo Fisher Scientific Inc. (TMO) and 2 other companies. The companies whose calls Dan Brennan spoke on are classified in the Healthcare sector.
“Maybe just to level set the guide, if you don't mind, just to start out.”
“Maybe could I start just on semitary volumes again, given how strong it was this quarter? So a couple of thousand tests from the weather recapture, so you're at 32,000.”
“I thought I would just, if you don't mind, just go back to, you know, VWR distribution and the investments that you made there to kind of stabilize share with the price.”
“Maybe first one just was already kind of asked in one way in terms of the guide. So if you're kind of flattish in Q2, it implies almost like a 40% back half sequential, like second half, first half.”
“Maybe just the first one on the $11 million cut on the growth expansion markets and the cut to volumes on exome genome to 30%. Just walk through the thinking there.”
TD Cowan
Analyst
Transcript header (unverified)
Diagnostics & Research · Healthcare
QTRX
Medical Devices · Healthcare
NTRA
Diagnostics & Research · Healthcare
AVTR
Medical Instruments & Supplies · Healthcare
PSNL
Diagnostics & Research · Healthcare
RVTY
Diagnostics & Research · Healthcare
